产品编号 :
Cas No. :
CAS No. |
81403-80-7 |
|---|---|
英文名称 |
N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide |
别名 |
n-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide;ALFUZOCIN;ALFUZOSIN;ALFUZOSIN HYDROCLORIDE;ALFUZOSINE;2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl) methylamino]propyl]tetrahydro-;N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxolane-2-carboxamide;N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide |
标准英文名 |
N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide |
分子式 |
C19H27N5O4 |
分子量 |
389.46 |
精确分子量 |
389.21 |
SMILES |
COC1=C(OC)C=C2C(=C1)N=C(N(C)CCCNC(=O)C1CCCO1)N=C2N |
标准SMILES |
COC1C=C2C(N)=NC(=NC2=CC=1OC)N(C)CCCNC(=O)C1CCCO1 |
用途 |
Treatment of benign prostatic hyperplasia (BPH) and hypertension; relief of urinary symptoms associated with BPH by reducing urethral resistance and bladder outlet obstruction through selective α1-adrenoceptor blockade; antihypertensive effect via α1-adrenergic receptor antagonism and direct vasodilation of vascular smooth muscle. |
InChIKey |
WNMJYKCGWZFFKR-UHFFFAOYSA-N |
|
|
评论 |
|---|